Safety and Efficacy Study in Hepatitis C Patients With PHN121
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability and efficacy of escalating dose of PHN121 when
administered orally in non-responder hepatitis C genotype 1 patients